What WISeR authorization delays mean for revenue cycle cash forecasting

A prior authorization model designed to accelerate Medicare decisions is leaving some providers without answers for weeks. Records released in September show technical failures disrupting review and two Wasteful and Inappropriate Service Reduction (WISeR) participants issuing 5,944 non-affirmations during the model’s first three months. One request reportedly remained unanswered for 83 days. The findings expose revenue at risk before a claim reaches billing: scheduled services can stall, clinical teams can repeat work, and expected reimbursement can slip outside the forecast period.

The new concern for revenue cycle leaders is whether provider workflows can identify and challenge stalled or adverse decisions quickly enough to protect care and cash. Under WISeR, reimbursement predictability depends on treating authorization exceptions as immediate financial exposure rather than waiting for them to become claim denials.

‍

The findings reveal exposure that denial reports cannot see. | Exposure Before Claims

‍Traditional denial reporting begins after a provider delivers a service, submits a claim, and receives an adverse payment decision. WISeR can create financial exposure earlier. A request may remain unresolved while the service stays unscheduled, moves to a later date, or disappears from the expected volume forecast.

No claim balance or denial code exists during this period. The organization still absorbs the cost of staff follow-up, clinical record retrieval, and schedule coordination. Finance also loses confidence in when the related reimbursement will enter the billing cycle.

A low final claim-denial rate could therefore coexist with deteriorating authorization performance. A provider may eventually secure approval through resubmission or peer-to-peer review while spending enough labor and time to weaken the margin attached to the service. Provider feedback included in the recently released records described procedures delayed for weeks and surgeries canceled while teams waited for authorization information.

Revenue cycle leaders need measures that reveal the exposure before a claim exists:

• Authorization inventory age: Days since submission, separated by standard and expedited requests.
• Service-date proximity: Pending cases approaching a scheduled procedure date.
• Revenue at risk: Expected reimbursement and contribution margin associated with unresolved requests.
• Resolution effort: Resubmissions and labor required to obtain an actionable decision.

These measures show whether the organization has a small group of clinically complex cases or a growing backlog capable of disrupting service-line cash flow.

‍

Provider response time matters as much as reviewer turnaround. | Response and Prioritization

‍CMS says WISeR participants will typically issue determinations within three days. Requests submitted through a WISeR participant’s electronic portal carry a 72-hour turnaround requirement, while requests routed through a Medicare Administrative Contractor may take longer. 

The newly released records show why provider performance cannot depend solely on these stated timelines. Thousands of early requests exceeded the three-day goal, and several hundred reportedly remained unanswered at the end of March. The records also describe system downtime, request misclassification, and communication failures between WISeR participants and Medicare Administrative Contractors.

Providers cannot control how quickly an external reviewer responds, but they can control how quickly the organization recognizes a missed deadline and starts escalation. A request left untouched for several additional days can force a procedure cancellation, shift billable care into another reporting period, or require staff to rebuild an authorization package.

Exception-response time should therefore become a revenue cycle metric. Leaders should measure the interval between a missed response target and the first meaningful intervention, then connect this interval to delayed services and reimbursement. The result reveals whether internal workflow latency is compounding external review delays.

‍

Financial priority should determine which cases move first.

‍A chronological work queue can leave high-value services waiting behind cases with less financial or clinical urgency. CFOs should require risk-based routing that prioritizes pending authorizations by:

• Expected reimbursement and contribution margin
• Proximity to the scheduled service date
• Clinical urgency
• Likelihood that additional documentation will change the decision

Finance leaders should also require authorization data to connect with scheduling and expected reimbursement. This view identifies revenue likely to move outside the forecast period and directs clinical expertise toward cases where intervention can still preserve the service date.

‍

Reduce the time lost to documentation gaps. | Documentation and Workflow

WISeR applies existing Medicare coverage requirements while changing how selected services move through prior authorization or pre-payment review. Providers can resubmit non-affirmed requests and pursue peer-to-peer review, although each additional step consumes labor and reduces the time available before the scheduled service.

A practical response begins with asking revenue cycle leaders to identify which documentation gaps cause the most non-affirmations and repeat work. Patient access, utilization review, and clinical documentation integrity teams can then update submission requirements by service, location, or ordering provider. Correcting recurring gaps upstream reduces case-by-case follow-up and protects the margin attached to reimbursement.

‍

Update workflows to prevent avoidable rework.

‍Authorization exceptions often move across scheduling, utilization review, and finance without one team owning the full resolution path. CFOs should require a shared workflow that records the initial submission, response deadline, supporting documentation, follow-up activity, and escalation status.

The workflow should also separate external review delays from internal documentation delays. External delays require escalation and exposure tracking. Internal delays require process correction. This distinction helps leadership direct resources toward the source of the backlog instead of adding staff across the entire function.

Clear ownership also strengthens accountability with CMS, Medicare Administrative Contractors, and WISeR participants. A complete record of submission dates, follow-up activity, and scheduling effects gives leadership the evidence needed to escalate recurring breakdowns.

Measure authorization exposure before it reaches A/R. | Authorization Exposure

‍A/R reports cannot capture revenue connected to care delayed before delivery. CFOs need an authorization exposure dashboard linked to the patient schedule and expected reimbursement. It should track:

• Pending authorization value by aging interval
• Scheduled revenue without an actionable determination
• Non-affirmation overturn rate and resolution time
• Labor required per completed authorization
• Revenue shifted outside the original forecast period

Denial rates should remain part of the analysis, although they cannot measure the full WISeR impact. Even overturned non-affirmations can increase cost-to-collect, delay cash, and weaken forecast accuracy.

Comparing results by service, location, and submission channel can reveal where documentation or routing failures concentrate. CFOs can use these findings to fund targeted corrections rather than apply a broad staffing response to a narrow workflow problem.

‍

How Vee Healthtek strengthens the response to WISeR exceptions. | Vee Healthtek Response

‍CFOs should manage WISeR exceptions as pre-service financial exposure rather than wait for claim-denial reports. Leadership needs a current view of requests exceeding response thresholds, scheduled services approaching deadlines, and reimbursement at risk of leaving the forecast period.

Vee Healthtek connects authorization activity with scheduling and expected reimbursement to show where delays create the greatest financial risk. Practitioner-led analysis pinpoints recurring documentation gaps and stalled handoffs, then informs workflow changes that accelerate clinical escalation and protect service dates.

This approach directs resources toward cases where intervention can preserve revenue while correcting the process failures driving repeat work. Leaders gain clearer visibility into authorization aging and forecast exposure, helping the organization reduce avoidable rework and build revenue resilience as technology-supported review changes the path to payment.

‍

Key takeaways.

• Manage unresolved WISeR authorizations as pre-service financial exposure rather than wait for claim-denial reports. 
• Replace chronological queues with risk-based routing that prioritizes cases carrying the greatest financial and clinical consequences. 
• Track recurring documentation deficiencies by service, location, and ordering provider to reduce repeat work.
• Separate external review delays from internal workflow delays so leadership can direct corrective action appropriately. 
• Connect authorization data with scheduling and expected reimbursement to identify revenue at risk of leaving the forecast period.